Virtu Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,504
| Closed | -$809K | – | 1567 |
|
|
2024
Q3 | $809K | Buy |
+11,504
| New | +$809K | 0.04% | 309 |
|
|
2022
Q4 | – | Sell |
-10,575
| Closed | -$896K | – | 1635 |
|
|
2022
Q3 | $896K | Buy |
+10,575
| New | +$896K | 0.08% | 220 |
|
|
2022
Q2 | – | Sell |
-12,122
| Closed | -$935K | – | 1602 |
|
|
2022
Q1 | $935K | Buy |
+12,122
| New | +$935K | 0.07% | 230 |
|
|
2021
Q4 | – | Sell |
-3,700
| Closed | -$286K | – | 1724 |
|
|
2021
Q3 | $286K | Buy |
+3,700
| New | +$286K | 0.03% | 738 |
|
|
2020
Q4 | – | Sell |
-18,026
| Closed | -$1.37M | – | 1449 |
|
|
2020
Q3 | $1.37M | Buy |
+18,026
| New | +$1.37M | 0.24% | 85 |
|
|
2019
Q4 | – | Sell |
-7,759
| Closed | -$523K | – | 1451 |
|
|
2019
Q3 | $523K | Buy |
+7,759
| New | +$523K | 0.04% | 495 |
|
|
2019
Q2 | – | Sell |
-14,015
| Closed | -$1.25M | – | 1456 |
|
|
2019
Q1 | $1.25M | Buy |
14,015
+10,029
| +252% | +$891K | 0.07% | 241 |
|
|
2018
Q4 | $339K | Sell |
3,986
-3,308
| -45% | -$281K | 0.02% | 652 |
|
|
2018
Q3 | $707K | Buy |
+7,294
| New | +$707K | 0.04% | 446 |
|
|
2018
Q1 | – | Sell |
-3,019
| Closed | -$269K | – | 1972 |
|
|
2017
Q4 | $269K | Sell |
3,019
-1,146
| -28% | -$102K | 0.01% | 1357 |
|
|
2017
Q3 | $388K | Buy |
+4,165
| New | +$388K | 0.02% | 1136 |
|
|
2016
Q4 | – | Sell |
-3,171
| Closed | -$293K | – | 447 |
|
|
2016
Q3 | $293K | Buy |
+3,171
| New | +$293K | 0.05% | 276 |
|
|
2016
Q1 | – | Sell |
-2,994
| Closed | -$314K | – | 401 |
|
|
2015
Q4 | $314K | Buy |
+2,994
| New | +$314K | 0.04% | 287 |
|
|
2015
Q3 | – | Sell |
-5,220
| Closed | -$714K | – | 307 |
|
|
2015
Q2 | $714K | Buy |
+5,220
| New | +$714K | 0.06% | 171 |
|
|
2014
Q4 | – | Sell |
-3,668
| Closed | -$265K | – | 300 |
|
|
2014
Q3 | $265K | Buy |
+3,668
| New | +$265K | 0.03% | 226 |
|